Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid neoplasms characterized by peripheral cytopenia, dysplasia, and a variable clinical course with about 30% risk to transform to secondary acute myeloid leukemia (AML). In the past 15 years, diagnostic evaluations, prognosticati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Valent, Peter, Orazi, Attilio, Steensma, David P., Ebert, Benjamin L., Haase, Detlef, Malcovati, Luca, van de Loosdrecht, Arjan A., Haferlach, Torsten, Westers, Theresia M., Wells, Denise A., Giagounidis, Aristoteles, Loken, Michael, Orfao, Alberto, Lübbert, Michael, Ganser, Arnold, Hofmann, Wolf-Karsten, Ogata, Kiyoyuki, Schanz, Julie, Béné, Marie C., Hoermann, Gregor, Sperr, Wolfgang R., Sotlar, Karl, Bettelheim, Peter, Stauder, Reinhard, Pfeilstöcker, Michael, Horny, Hans-Peter, Germing, Ulrich, Greenberg, Peter, Bennett, John M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Priority Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650276/
https://ncbi.nlm.nih.gov/pubmed/29088721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19008
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi